Effect of Continuous Combined Hormone Replacement Therapy with Oestradiol Valerate and Dienogest on Mammographic Density in Postmenopausal Women

Abstract

peri menopausal during the phone call. Two-thirds with documentation had children. Callers were taking a variety of therapies, both prescribed and self-administered. Overall they were more likely to be taking complementary therapies than prescribed medications. One-third suggested that their GP was unsympathetic. 40 women admitted that working days were lost due to PMS and telephone volunteers reported that desperation was manifest during the call. Conclusions. The helpline is an important part of the support offered by NAPS for PMS sufferers and their partners. As these calls probably represent a fraction of desperate women, it is important to raise awareness of this condition and provide different forums for women to both receive support and information. This may involve providing information in other minority languages. The use of open access genito-urinary clinics by women over the age of 45

S100A4 overexpression proves to be independent marker for breast cancer progression

“…In fact most deaths of women with breast cancer arise not as a result of primary tumor but from its metastatic spread to distant sites in the body [ 26 , 27 ]. Once spread and secondary masses are formed, breast cancers are usually incurable [ 28 ]. Yet a sensitive and reliable method for early metastasis in breast cancer is still not available.…”

Densidade mamográfica em mulheres climatéricas em uso de terapia de reposição hormonal

“…Vários estudos 20,26,27,29,31,[33][34][35] constataram que o aumento da densidade é maior em usuárias de esquemas contendo estrógeno e progestágeno na forma continua ou seqüencial, quando comparado ao uso de estrógenos isolados. No grupo das 70 pacientes analisadas, 80% utilizou esquemas de TRH estroprogestativa.…”